January 12, 2022

Gshwend et al v. Abbott Laboratories et al

View recent docket activity


Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.


Coverage

  1. June 23, 2022

    'Absurd' Loophole Keeping Abbott Formula Suits Federal Fails

    An Illinois federal judge overseeing multidistrict litigation alleging Abbott Laboratories' Similac infant formula caused a deadly illness in premature babies on Wednesday remanded four of the cases to state court, finding that allowing the medical company to use the "snap removal" loophole would "produce absurd results."


Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!